Tag Archives: Stock

Why these pot stocks smoked the ASX today

Why These Pot Stocks Smoked the ASX Today

Why These Pot Stocks Smoked the ASX Today

It certainly has been a great day for pot stocks on the ASX. This morning Federal Health Minister Greg Hunt announced that the government would allow medical marijuana companies to distribute cannabis oils and medications in Australia within the next couple of months.

Surna leadership reflector and Agrisoft Agreement and shares call results and board of directors and cloud 9 wholesale

Surna Inc. Converts $2.76 Million of Debt

BOULDER, Colo., Feb. 21, 2017 /Weed Wire/ — Surna Inc. (OTCQB: SRNA) converted $2.76 million of its 10% convertible promissory notes, consisting of approximately $2.28 million in principal and $480,000 of accrued interest, into approximately 18 million shares of newly issued common stock and cash payments of less than $200,000.

Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?

Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?

Canopy Growth Corp. has garnered the most attention and established itself as the market leader; however, there is another company in the Canadian marijuana industry that could emerge as a potential winner.

Canopy Growth Corp. Could Crash Over Use of Banned Pesticides

Canopy Growth Corp. Could Crash Over Use of Banned Pesticides

Canopy Growth’s recently acquired Mettrum Ltd. stated that it wrote off $800,000 of costs owing to a series of recalls over the use of a banned pesticides. The staff at Mettrum feared detection from authorities, so they hid the pesticides in the office’s ceiling tiles.

Millionaires are Being Made From Cashing in on This Cannabis Stock

Millionaires Are Being Made From Cashing in on This Pot Stock

Since seeing all the buzz and craze these companies are causing in the marketplace, we’ve been hot on the trail of companies tied to the cannabis sector. The budding marijuana industry has spawned several high flying stocks lately, like Mentor Capital Inc.

Top 5 States for Marijuana Stocks

Top 5 States for Marijuana Stocks

Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.

Should Investors Consider Canopy Growth Corp.?

Should Investors Consider Canopy Growth Corp.?

Investors are incredibly excited about Canopy Growth Corporation. But we’re now looking at a situation where the stock has increased quite aggressively thanks mostly to the belief that the future is bright. And there are still many investors sitting on the sidelines wondering if they should consider this company.

How Big Could the Opportunity Be for Marijuana Stocks in California?

How Big Could the Opportunity Be for Marijuana Stocks in California?

The market for marijuana is exploding as Americans overwhelmingly embrace legalization. Analysts are projecting tens of billions of dollars in future marijuana sales, making this an intriguing market for investors.

Zynerba

Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock

DEVON, Pa., Jan. 19, 2017 /Weed Wire/ — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced the pricing of an underwritten public offering of 2.8 million shares of its common stock at a price of $18.00 per share, with expected gross proceeds to Zynerba of $50.4 million.

The Fast Moves on MassRoots Inc(OTCMKTS:MSRT) as Pot Stock Sector Booms

The Fast Moves on MassRoots Inc as Pot Stock Sector Booms

MassRoots Inc(OTCMKTS:MSRT) describes itself as one of the largest technology platforms for the regulated cannabis industry. MSRT is at the right place at the right time as the pot sector has been seeing huge growth in recent months as medical MJ products in the U.S. alone are projected to generate up to $35 Billion by 2020.

Top Marijuana Stocks to Watch in 2017

Top Marijuana Stocks to Watch in 2017

Sales in the legal marijuana industry are skyrocketing, which is why Money Morning created a list of the top marijuana stocks to watch in 2017. But because marijuana is still illegal under federal law, and many of the marijuana stocks on the market are so volatile, this isn’t a list of recommendations. Rather, it’s a list of marijuana stocks they are watching closely in 2017.

Canadian marijuana stocks regain momentum after Christmas

Canadian Marijuana Stocks Regain Momentum After Christmas

In the last few months, the medical marijuana growers have dominated the trading activity on the TSX Venture in terms of dollar volume almost exclusively, belying a persistent interest from investors in Canada and the United States.

Vitality Biopharma: A Seriously Undervalued Cannabis Stock

Vitality Biopharma: A Seriously Undervalued Cannabis Stock

While many investors were drawn in by the myth that millions would be made by investing in the companies that purportedly planned to cultivate and sell medical and leisure based marijuana, they should have been focused on investing in companies that are intent on utilizing the plant’s cannabinoid properties, which are consistently demonstrating extraordinary benefit in treating a host of medical conditions.

MassRoots Users Funding Round and Crosses Half a Million Users and NASDAQ

MassRoots Enters into Definitive Agreement to Acquire Whaxy in Cash and Stock Deal

DENVER, Dec. 15, 2016 /Weed Wire/ — MassRoots, Inc. (OTCQB:MSRT), one of the leading technology platforms for the cannabis industry, is pleased to report it has entered into a definitive agreement to acquire DDDigtal Inc. d.b.a. “Whaxy” & Cannabuild for $100,000 cash and 2,926,830 million shares of MassRoots’ common stock.

Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock?

Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock?

The fed’s report was largely positive for the recreational marijuana industry when it was released Tuesday. Aurora Cannabis stock was one of the biggest pot stock beneficiaries of the announcement, but has since had a regression in share price.

Cannabis Company Files to List on the New York Stock Exchange

Cannabis Company Files to List on the New York Stock Exchange

New Cannabis Ventures broke the news Monday evening. It will be the first publicly-traded cannabis-related Real Estate Investor Trust or REIT and, if approved, would be the first cannabis company to be traded at the venerable NYSE.

MJIC Logo

Newly Launched MJIC Marijuana Index Tracks Positive Third-Quarter Progress for Frontier Legal Cannabis Market

LOS ANGELES, Oct. 13, 2016 /Weed Wire/ — MJIC Inc. has launched its North American Marijuana Index (the “Index”), a stock index designed to track the leading public cannabis companies in the U.S. and Canada.

Marijuana-Related Company Charged with Scheming Investors

WASHINGTON, Sept. 16, 2016 /Weed Wire/ — The Securities and Exchange Commission today announced fraud charges in a scheme involving illegal stock sales and false financial filings of a company that makes containers for growing marijuana.

OrganiGram Inventory

OrganiGram Announces Issuance of Stock Options

MONCTON, New Brunswick, Sept. 2, 2016 /Weed Wire/ — OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (“OrganiGram” or the “Company”) announces that it has issued an aggregate of 835,600 incentive stock options to various directors and officers of the Company at an exercise price of $1.42 per share.

Pineapple Express

Pineapple Express Co-Founder Comments on Temporary Trading Suspension by the SEC

LOS ANGELES, May 12, 2016 /Weed Wire/ — P. Vincent Mehdizadeh, Co-Founder of PINEAPPLE EXPRESS, INC. (OTC Pink:PNPL) (the “Company”), commented on the SEC’s temporary suspension of PNPL trading from April 28, 2016 through May 11, 2016. The Company’s stock is eligible to resume trading May 12, 2016.

GW Pharma

GW Pharma Reports Positive Results and Stock More than Doubles by Mid-Day

On March 14, 2016, GW Pharmaceuticals (NASDAQ: GWPH), a biopharma company with two promising cannabis-based medications, announced positive results for the first pivotal Phase 3 study of Epidiolex, a CBD-based medicine, in treating Dravet syndrome, a severe form of pediatric epilepsy.

Eco Science

Eco Science Solutions, Inc. Announces 1 Million Share Buyback and Cancellation as Part of Its Ongoing Stock Buyback Program

MAUI, Hawaii, Feb. 26, 2016 /Weed Wire/ — Eco Science Solutions, Inc. (OTCBB: ESSI), a vertically focused e-commerce company in the cannabis industry, today announced that it has formally completed and canceled 1,000,000 shares of common stock, thus enhancing shareholders present-day equity value in the Company.

Capital Markets

Making CBD, and the Capital Markets, Bioavailable

Chris Bunka, the CEO and Chair at Lexaria Corp. (CSE: LXX) (OTCQB: LXRP), suspects that market-makers and broker-dealers are engaged in something potentially illegal and certainly untoward in connection with the stock of the company.

Conference Call

Prepping for MassRoots’ Shareholder Conference Call

It has been a couple of months since MassRoots (OTCQB: MSRT) became a publicly-traded company. Since that time, the company has struggled to see its share price break above the original offering price.

Nevada Based Marijuana Testing Lab Company, MA & Associates, LLC Becomes a 100% Wholly-Owned Subsidiary Of Pazoo

WHIPPANY, N.J., June 24, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to report that on Wednesday, June 3, 2015, Pazoo acquired the remaining 60% of MA & Associates, LLC in exchange for 900,000 shares of Pazoo’s Series C. Preferred stock. This now makes MA & Associates, LLC a 100% wholly-owned subsidiary of Pazoo.

GWPH

GWPH Business Plan: Alan Brochstein’s Thoughts

Alan Brochstein has followed quite closely recent developments in the medical and financial world insofar as they have affected GW Pharmaceuticals (NASDAQ: GWPH), the developer of two promising cannabis-based medications.


Page 1 of 212
Top